Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial to Evaluate Levodopa as Treatment to Improve Vision in Individuals With Albinism

NCT01176435 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT01176435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01176435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial to Evaluate Levodopa as Treatment to Improve Vision in Individuals With Albinism
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2014
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albinism